SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001615774-15-001698
Filing Date
2015-07-06
Accepted
2015-07-02 18:50:01
Documents
6
Period of Report
2015-06-30
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K s101410_8k.htm 8-K 39123
2 EXHIBIT 3.1 s101410_ex3-1.htm EX-3.1 9447
3 EXHIBIT 3.2 s101410_ex3-2.htm EX-3.2 149629
4 EXHIBIT 3.3 s101410_ex3-3.htm EX-3.3 137506
5 EXHIBIT 4.1 s101410_ex4-1.htm EX-4.1 92926
6 EXHIBIT 10.1 s101410_ex10-1.htm EX-10.1 404622
  Complete submission text file 0001615774-15-001698.txt   834797
Mailing Address 550 SYLVAN AVENUE SUITE 101 ENGLEWOOD CLIFFS NJ 07632
Business Address 550 SYLVAN AVENUE SUITE 101 ENGLEWOOD CLIFFS NJ 07632 201 608-5102
Intellect Neurosciences, Inc. (Filer) CIK: 0001337905 (see all company filings)

IRS No.: 208329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-55268 | Film No.: 15971492
SIC: 2834 Pharmaceutical Preparations